Live News EARNINGS H impact Jul 23, 2026, 11:01 AM UTC

NovoCure Raises FY2026 Sales Guidance from $690.000M-$710.000M to $710.000M-$725.000M vs $708.743M Est

NovoCure (NASDAQ: NVCR ) raises FY2026 sales outlook from $690.000 million-$710.000 million to $710.000 million-$725.000 million vs $708.743 million estimate.

NVCR

SquawkNews Newsroom

NovoCure (NASDAQ: NVCR ) raises FY2026 sales outlook from $690.000 million-$710.000 million to $710.000 million-$725.000 million vs $708.743 million estimate.